Task: Answer the following question about the molecule with SMILES CCCCOc1ccc(CC(=O)NO)cc1.
Question: Please describe this drug.
Completion: Bufexamac is a non-steroidal anti-inflammatory drug (NSAID) under the market name Droxaryl, Malipuran, Paraderm and Parfenac. It is typically administered topically for the treatment of subacute and chronic eczema of the skin, including atopic eczema and other inflammatory dermatoses, as well as sunburn and other minor burns, and itching. It has also been used in suppositories in combination with local anaesthetics indicated for haemorrhoids. The use of bufexamac has been discontinued in Canada and the United States, which may be due to undetermined clinical efficacy and a high prevalence of contact sensitization. Bufexamac was also withdrawn by the EMA in April 2010.
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CCCCOc1ccc(CC(=O)NO)cc1
CCCCOC1=CC=C(C=C1)CC(=O)NO
2-(4-butoxycyclohexa-1,3,5-trien-1-yl)-N-hydroxyacetamide
Please describe this drug.